Additionally, a separate study found that a structural derivative of emodin, emodin succinyl ester (ESE), inhibits malignant proliferation and migration of hepatocellular carcinoma by suppressing the interaction between androgen receptor (AR) and enhancer of zeste homolog 2 (EZH2) [115]. This evidence concerns the gene EZH2 and hepatocellular carcinoma.